Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Wearable neuromodulation to help bowel symptoms after spinal cord injury

Official title: An Early Feasibility Study of Using the AccelBand, a Leg-worn Transcutaneous Neuromodulation (TNM) Device, for Neurogenic Bowel Dysfunction (NBD) in People With Spinal Cord Injury (SCI)

Run by University of Michigan · NCT07171489 · Data updated 2026-11-12

This study tests a wearable device that uses transcutaneous neuromodulation to see if it can lessen neurogenic bowel dysfunction in people with spinal cord injury, compared to a sham treatment.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedJuly 2026
Main results expectedNovember 2029
Study endsNovember 2029
Registry record updatedJuly 6, 2026
Trial IDNCT07171489 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with traumatic or non-traumatic SCI above T12, AIS B/C/D with chronic (>6 months) SCI and neurogenic bowel dysfunction who can consent.

Probably not a fit

Patients with certain medical comorbidities, implanted electrical devices, or conditions excluding participation may not experience benefit from this therapy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines whether a wearable transcutaneous neuromodulation device can reduce constipation symptoms linked to neurogenic bowel dysfunction in individuals with spinal cord injury. Participants are randomized to receive TNM at a sham point, TNM at a leg point, or an open-label leg-point TNM, with outcomes comparing baseline to post-therapy. The device aims to improve autonomic function and bowel symptoms, using standardized questionnaires and anorectal testing to assess results. Eligible participants include adults with SCI above T12, with chronic SCI and documented NBD, who consent to participate. Exclusion criteria screen for cognitive impairment, major GI surgeries (beyond a few common procedures), diabetes, psychiatric illness, substance abuse, implanted electrical devices, opioid use, pregnancy, active inflammatory bowel disease, ventilator dependence, or severe autonomic dysreflexia.

Why it matters

Potential benefit: If successful, participants could experience improved bowel function and quality of life related to neurogenic bowel dysfunction after spinal cord injury.

How similar studies have gone: Previous studies in neuromodulation approaches for bowel function have shown mixed but promising signals, making this approach plausible but not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Traumatic or non-traumatic spinal cord injury (SCI)
* SCI level above the twelfth thoracic vertebra (T12)
* SCI classified as Sensory Incomplete (AIS B), C, or D
* Post-SCI time ≥ 6 months;
* Neurogenic bowel dysfunction (NBD) as a result of SCI
* Willing to sign the informed consent form

Exclusion Criteria:

* Significant cognitive impairment, impeding the ability to provide informed consent or complete the questionnaire
* Prior gastrointestinal surgeries other than uncomplicated appendectomies, cholecystectomy or cesarean sections
* Known diagnosis of diabetes mellitus
* Known current or past severe significant psychiatric disorder
* Known current substance abuse
* Implanted medical devices for electrical stimulation (e.g. cardiac pacemaker)
* Taking opioid medications on a regular daily basis
* Currently pregnant or actively planning a pregnancy
* Active inflammatory bowel disease
* Ventilator dependency
* Severe autonomic dysreflexia
* No preservation of the sacral spinal reflexes: bulbocavernosus, patella, or Achilles
* Complete absence of sensation in the leg (since it is needed for calibrating the TNM intensity)

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.